These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 14624437)
1. Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach. Sader MA; De Moor M; Pomerantsev E; Palacios IF Catheter Cardiovasc Interv; 2003 Dec; 60(4):536-9. PubMed ID: 14624437 [TBL] [Abstract][Full Text] [Related]
2. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921 [TBL] [Abstract][Full Text] [Related]
3. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia. Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614 [TBL] [Abstract][Full Text] [Related]
4. Migraine headache relief after transcatheter closure of patent foramen ovale. Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692 [TBL] [Abstract][Full Text] [Related]
5. [Percutaneous closure of patent foramen ovale: preliminary experience with the PFO Star]. Stauffer JC; Serra M; Juillard JM; Seydoux C; Perret F; Owlya R; Savcic M; Beuret P; Goy JJ Arch Mal Coeur Vaiss; 2004 Jan; 97(1):37-41. PubMed ID: 15002709 [TBL] [Abstract][Full Text] [Related]
6. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure. Dubiel M; Bruch L; Liebner M; Schmehl I; Winkelmann A; Rux S; Sonntag S; Wulff H; Grad MO; Kleber FX J Interv Cardiol; 2007 Aug; 20(4):275-81. PubMed ID: 17680857 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous transcatheter closure of patent foramen ovale. Chatterjee T; Ritz A; Rehders TC; Ince H; Kische S; Petzsch M; Nienaber CA Minerva Cardioangiol; 2006 Feb; 54(1):31-9. PubMed ID: 16467740 [TBL] [Abstract][Full Text] [Related]
8. Successful Percutaneous Transcatheter Patent Foramen Ovale Closure Through The Right Internal Jugular Vein Using Stiff Amplatzer Catheter With A Reshaped Tip. Fanari Z; Hammami S; Hopkins JT Del Med J; 2016 Aug; 88(8):238-241. PubMed ID: 28751787 [TBL] [Abstract][Full Text] [Related]
9. Jugular approach for percutaneous closure of atrial septal defect. Papa M; Gaspardone A; Fragasso G; Camesasca C; Conversano A; Tomai F; Versaci F; Margonato A Ital Heart J; 2004 Jun; 5(6):466-9. PubMed ID: 15320573 [TBL] [Abstract][Full Text] [Related]
10. Successful percutaneous transcatheter patent foramen ovale closure through the right internal jugular vein using a steerable catheter. Hascoet S; Fraisse A; Elbaz M Catheter Cardiovasc Interv; 2013 Oct; 82(4):E598-602. PubMed ID: 23413211 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of a patent foramen ovale via left axillary vein approach with the Amplatzer Cribriform septal occluder. Carter LI; Cavendish JJ J Interv Cardiol; 2008 Feb; 21(1):28-31. PubMed ID: 18254787 [TBL] [Abstract][Full Text] [Related]
13. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event]. Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of patent foramen ovale in patients with migraine headache. Spies C; Schräder R J Interv Cardiol; 2006 Dec; 19(6):552-7. PubMed ID: 17107372 [TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Sievert H; Fischer E; Heinisch C; Majunke N; Roemer A; Wunderlich N Circulation; 2007 Oct; 116(15):1701-6. PubMed ID: 17893276 [TBL] [Abstract][Full Text] [Related]
16. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164 [TBL] [Abstract][Full Text] [Related]
17. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts. Rigatelli G; Giordan M; Braggion G; Aggio S; Chinaglia M; Zattoni L; Milan T; Cardaioli P Cardiovasc Revasc Med; 2007; 8(4):248-50. PubMed ID: 18053946 [TBL] [Abstract][Full Text] [Related]
18. Should we be using bilateral carotid distal protection devices during the percutaneous closure of patent foramen ovale in patients with a history of paradoxical embolus? Richardson G; Keeble TR; Rothman MT Catheter Cardiovasc Interv; 2004 Jun; 62(2):272-5. PubMed ID: 15170725 [TBL] [Abstract][Full Text] [Related]
19. Analysis of left and right ventricular Doppler tissue imaging in patients undergoing percutaneous closure of patent foramen ovale. Yalonetsky S; Schwartz Y; Lorber A J Invasive Cardiol; 2007 Jun; 19(6):252-4. PubMed ID: 17541124 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder. Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]